- info@pro1laser.com
- 1-604-649-1234
- Monday 07.00 am - 12.00 pm Sunday
Menu
Hair loss is a condition that has kept many people baffled for years. Scientifically known as alopecia, this condition affects both men and women and may be caused due to a plethora of factors such as genetics, hormonal discrepancies, nutrition and lifestyle disorders. For years, the solution to hair loss has been medication and surgical hair transplant.
These medications, including Minoxidil and Finasteride, are riddled with side effects such as the itchy scalp, sexual dysfunction, infection on the scalp etc. Minimal side effects and non-invasive treatment are the two important factors that patients seek in hair fall treatments.
The QR678® Neo therapy is a proprietary, first in class hair fall & hair regrowth therapy, which has revolutionized the treatment of hair fall in alopecia. This formulation was invented in India & has been named QR678 inspired by the new generation ubiquitous presence of “Quick Response“ QR code. 678 in Morse Code signifies “there is no answer”. This formulation has been named QR678® to signify a “Quick Response to a disease which earlier had no answer”. The US and India patented QR678® Neo therapy is backed by 13+ clinical papers published in top international peer-reviewed journals. The biomimetic peptide formulation arrests hair fall & increases the thickness, number, and density of existing hair follicles leading to greater coverage in hair loss. The polypeptides used in the formulation mimic the action of specific human hair growth related growth factors that are naturally present in our scalp, making it natural growth factor-based treatment. The polypeptides penetrate deep into the scalp and provide nourishment to the scalp, which results in hair growth.
Growth factor concentrate (GFC) is a treatment approach in the field of hair restoration that involves the use of growth factors to potentially stimulate hair growth and improve the overall health of hair follicles. Growth factors are naturally occurring proteins in the body that play a crucial role in cell growth and tissue repair. In the context of hair loss treatment, GFC is often derived from the patient’s own blood, similar to platelet-rich plasma (PRP) therapy but in specialized tubes that supposedly help in further concentration of the growth factors.
GFC or Growth Factor Concentrate is a solution derived from your own blood that contains a high concentration of growth factors that aid in hair regrowth. GFC treatment, although readily available, is met with a number of hurdles and challenges. They are a non-standardized treatment modality for hair regrowth that may not give consistent results. There is a dire lack of research studies in medical literature that back the rationale behind the use of GFC for hair regrowth.
The QR678® Neo therapy is a proprietary, first in class hair fall & hair regrowth therapy, which has revolutionized the treatment of hair fall in alopecia. This formulation was invented in India & has been named QR678 inspired by the new generation ubiquitous presence of “Quick Response“ QR code. 678 in Morse Code signifies “there is no answer”. This formulation has been named QR678® to signify a “Quick Response to a disease which earlier had no answer”.
The US and India patented QR678® Neo therapy is backed by 13+ clinical papers published in top international peer-reviewed journals. The biomimetic peptide formulation arrests hair fall & increases the thickness, number, and density of existing hair follicles leading to greater coverage in hair loss. The polypeptides used in the formulation mimic the action of specific human hair growth related growth factors that are naturally present in our scalp, making it natural growth factor-based treatment. The polypeptides penetrate deep into the scalp and provide nourishment to the scalp, which results in hair growth.
The efficacy of GFC therapy for treatment of hair loss by increasing the hair count, thickness and growth phase is still under research and there is no official conclusive evidence about the effectiveness of PRP
We conducted a clinical study to compare and evaluate the effectiveness of QR678® Neo and GFC, to better understand the results of both the treatment modalities. A prospective, comparative study was conducted.
Clinical assessment was done at baseline, 6 months and 1 year by:
Group A (QR678® Neo) showcased clinically and statistically significant results : ● Better increase in hair shaft diameter (thickness) ● Better increase in hair follicle density ● Superior retention of the hair follicles at 12 months ● Decrease in vellus hair/ miniaturized hair ● Clinically negligible postoperative side effects ● Least pain, as compared to GFC ● Least clinical chair-side time
The QR678® Neo therapy arrests hair fall & increases the thickness, number & density of existing hair follicles, leading to greater coverage in patients with alopecia. Since, the polypeptides used in QR678® Neo are anyways present in scalp full of hair (they get decreased in scalps which have hair fall), it is the enrichment of the scalp skin with these polypeptides which cause hair growth. Since these polypeptides are anyways normally present in the scalp, replenishing the scalp with these is not artificial and does not have any side effects
Unlike currently available hair fall treatments like minoxidil & finasteride, the QR678® Neo therapy is almost completely devoid of side effects. It is locally administered over the scalp skin by mesotherapy & as such is not absorbed into the systemic circulation. Unlike currently available hair transplant therapies like Follicular Unit Extraction (FUE) & Follicular Unit Transplantation (FUT), the QR678® Neo is non invasive, non surgical & therefore safer & more affordable. The QR678® Neo therapy works very well in androgenetic alopecia or male pattern baldness & female pattern hair loss. The QR678® Neo therapy has also demonstrated encouraging results in post chemotherapy induced hair loss, treatment of hair conditions like seborrheic dermatitis & in immunogenic diseases like alopecia areata.
QR678® Neo consists of a proprietary blend of natural growth factors, identical to those found in a healthy scalp, ensuring its safety for universal application. This precise formulation contains targeted concentrations of specific factors known to promote hair growth. With QR678® Neo, patients experience no side effects. The treatment is administered on an outpatient basis, with visible results emerging as early as eight weeks after commencement. Hear directly from our patients about their experiences with the QR678® Neo hair loss treatment.
QR678® Neo treatments involve 5 to 10 sessions, spaced approximately 2-3 weeks apart. Visible improvements can be observed within a few weeks following the commencement of the therapy. Once optimal results are attained, further injections are unnecessary unless hair loss recurs. This enduring effect is due to QR678® Neo’s capacity to rejuvenate hair follicles. Discover the reasons behind QR678® Neo’s high efficacy in reducing hair loss and enhancing hair regrowth.
QR678® Neo offers a safe treatment experience without any side effects, enabling you to continue with your day-to-day activities right after each session. It is recommended to use a mild shampoo at least a day post-treatment and refrain from scratching or rubbing the area treated. If any concerns arise, consult your treatment provider for guidance.
Genetic hair loss, often hereditary and observed in both men and women, can indeed be managed effectively if treatment commences early. This type of hair loss, which frequently runs in families, typically follows a distinctive pattern: an M or W shape in men and thinning along the hair part in women. If you have a family history of patterned baldness, it’s crucial to monitor your hair health closely and consult a doctor at the first sign of hair loss.
There are several well-established treatments for genetic hair loss, including:
Alopecia following chemotherapy is a widespread and emotionally impactful side effect of cancer treatments. The fear of hair loss often deters patients from undergoing necessary therapies. While hair loss from chemotherapy is usually temporary, regrowth can take months or even up to a year. However, recent advancements in treatment can expedite recovery:
These treatments offer hope and options for those facing hair loss due to chemotherapy, providing a path to recovery and helping to mitigate one of the most challenging aspects of cancer treatment.
QR678® Neo is a first-of-its-kind product developed by a group of clinical scientists after extensive research.
